| Claudia L Grogean, MD | |
|
134 Grandview Ave, Suite 210, Waterbury, CT 06708-2507 | |
| (203) 754-2535 | |
| (203) 754-0788 |
| Full Name | Claudia L Grogean |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 134 Grandview Ave, Waterbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497945315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 045616 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Waterbury Hospital | Waterbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
Meanwhile, other news outlets report on the challenges private practice physicians face in serving their patients and their own bottom lines, and ProPublica explores drug company payments to doctors.
Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.
After a strong Q4 in 2009, net sales decreased 14% in Q1 to SEK 2,943 million (3,437). Mainly currency effects but also increased competition for Astelin and Optivar reduced sales by more than SEK 400 million, compared with the same period last year.
› Verified 3 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
Meanwhile, other news outlets report on the challenges private practice physicians face in serving their patients and their own bottom lines, and ProPublica explores drug company payments to doctors.
Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.
After a strong Q4 in 2009, net sales decreased 14% in Q1 to SEK 2,943 million (3,437). Mainly currency effects but also increased competition for Astelin and Optivar reduced sales by more than SEK 400 million, compared with the same period last year.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Claudia L Grogean, MD 134 Grandview Ave, Suite 210, Waterbury, CT 06708-2507 Ph: (203) 754-2535 | Claudia L Grogean, MD 134 Grandview Ave, Suite 210, Waterbury, CT 06708-2507 Ph: (203) 754-2535 |
News Archive
Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells.
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
Meanwhile, other news outlets report on the challenges private practice physicians face in serving their patients and their own bottom lines, and ProPublica explores drug company payments to doctors.
Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.
After a strong Q4 in 2009, net sales decreased 14% in Q1 to SEK 2,943 million (3,437). Mainly currency effects but also increased competition for Astelin and Optivar reduced sales by more than SEK 400 million, compared with the same period last year.
› Verified 3 days ago
Janet L Vodra, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Grandview Ave, Suite 202, Waterbury, CT 06708 Phone: 203-755-2344 Fax: 203-573-8166 | |
Dr. Meghan Marie Slemmens, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 140 Grandview Ave, Waterbury, CT 06708 Phone: 203-755-2344 Fax: 203-573-8166 | |
Dr. John Kaczmarek, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 134 Grandview Ave, Suite 210, Waterbury, CT 06708 Phone: 203-754-2535 Fax: 203-756-9921 | |
Mary L Zozulin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 60 Westwood Ave, Suite 100, Waterbury, CT 06708 Phone: 203-573-1425 | |
Clare Ventre, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 60 Westwood Ave, Suite 100, Waterbury, CT 06708 Phone: 203-573-1425 Fax: 203-573-8236 | |
Marc G. Hochler, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 56 Franklin St, Waterbury, CT 06706 Phone: 203-709-6000 | |
Jose Eguia, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 60 Westwood Ave, Suite 200, Waterbury, CT 06708 Phone: 203-574-5501 Fax: 203-596-0912 |